Benefits

CTSA-funded sites known for cutting edge, performance driven research
Access to multidisciplinary investigators and study teams
Good Clinical Practice (GCP)-trained personnel at each performance site
Established Standard Operating Procedures for quality assurance
Consistent and effective communication among MARCH leadership and study teams
Mission consistent with national research goals of regionalization and collaboration
All sites are accredited by the Association for the Accreditation of Human Research Protections Program (AAHRPP)

Implement multisite research protocols more quickly and cost-effectively
Effective administration and coordination mechanisms through a centralized model
Dedicated leadership and study personnel at each site to enhance communication, continuity, and to assist with coordination
Standardized data management across sites via clinical trial management system software
Streamlined regulatory approval process providing a single Institutional Review Board (IRB) of record
Simplified fiscal management: one contract, one budget, one contact
Access to larger, more diverse populations leading to increased generalizability

Recruitment across multiple Midwest sites optimizing accrual success, particularly in studies of rare disease states or those that require an inordinately large sample size
Geographic reach of ethnic and socioeconomic representation across the Midwest enabling study of the differences in the causes, occurrence, and characteristics of diseases across populations
Collective power of large and diverse subject populations from academic institutions across multiple states facilitating rapid enrollment
Access to greater than 22 million residents across member sites